ERCC6 and breast cancer: A study reported by Fu et al in 2017 demonstrated that hsa-let-7c-5p may act as a tumor suppressor of breast cancer by negatively regulating ERCC6, providing a new strategy for breast cancer treatment (Fu et al., 2017).